Immunocore announces 2026 strategic priorities at 44th Annual J.P. Morgan Healthcare Conference Reaching more metastatic uveal melanoma patients ...
Eli Lilly will buy autoimmune drug developer Ventyx Biosciences for $1.2 billion in cash, the companies said on Wednesday, ...
Flow Space on MSN
The silent burden of lupus flares: How to advocate for yourself when symptoms don't add up
Lupus is often marked by flares, which is when symptoms are usually more obvious.
Alumis said envudeucitinib, its oral TYK2 inhibitor, achieved multiple skin-clearance efficacy goals in two Phase 3 clinical ...
Understanding what autoimmune diseases are, what triggers them and how they’re treated can be a powerful first step toward ...
Zenas BioPharma said on Monday its experimental drug cut the risk of flare-ups of a rare autoimmune disease in a late-stage study, but its shares fell 57% as the drug's efficacy fell short of ...
Polpharma Biologics, a leading biopharmaceutical company specializing in the development and manufacturing of biosimilars, is thrilled to announce the signing of a landmark licensing agreement with ...
A new study has linked air pollution exposure and immune-system changes that often precede the onset of autoimmune diseases. McGill University researchers analyzing Ontario data found that fine ...
(MENAFN- AETOSWire) (BUSINESS WIRE )-- Polpharma Biologics, a leading biopharmaceutical company specializing in the development and manufacturing of biosimilars, is thrilled to announce the signing of ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback